Hospital
Charles a Dean Memorial Hospital
Charles a Dean Memorial Hospital was paid $617K by Medicaid between Jan 2018 and Dec 2024, across 113 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 14% of everything it billed.
33Billing provider infoCHARLES A DEAN MEMORIAL HOSPITAL
GREENVILLE, ME 04441
GREENVILLE, ME 04441
33aNPI1659388213assigned 08/03/2006
33bProvider typeCritical Access Hospital
28Total paid$617K
24GClaims128,792
24DCodes billed113
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Maine
Rank by total paid#11 of 14
Median peer was paid$1.76M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,162 | $95K | |
| 2019 | 17,537 | $100K | |
| 2020 | 16,363 | $71K | |
| 2021 | 24,875 | $90K | |
| 2022 | 20,917 | $74K | |
| 2023 | 20,469 | $99K | |
| 2024incomplete | 13,469 | $88K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 16,352 | 8,086 | $84K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 9.6% | 3,784 | 2,489 | $59K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 764 | 514 | $51K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.6% | 12,423 | 6,051 | $41K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.2% | 2,938 | 1,841 | $38K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.4% | 1,804 | 1,209 | $33K |
| 11721 | 4.6% | 5,497 | 2,664 | $28K | |
| 99310 | Prolong nursin fac eval 15m | 4.5% | 1,140 | 966 | $28K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3.8% | 4,312 | 1,404 | $24K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.8% | 3,154 | 1,058 | $24K |
| 80053 | Comprehensive metabolic panel | 3.4% | 5,955 | 5,408 | $21K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.0% | 2,645 | 1,399 | $19K |
101 more codes
| 99308 | Subsequent nursing facility care, per day, straightforward | 2.3% | 1,168 | $14K |
| 51798 | 2.0% | 492 | $13K | |
| 99336 | 1.8% | 354 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 3,531 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.4% | 3,456 | $9K |
| 90832 | Psychotherapy session, about 30 minutes | 1.4% | 3,149 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 7,152 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 489 | $7K |
| 52000 | 1.0% | 148 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,381 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,074 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,602 | $6K |
| 99337 | <1% | 184 | $6K | |
| Q3014 | Telehealth originating site facility fee | <1% | 2,955 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 158 | $5K |
| 76775 | <1% | 198 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 498 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,200 | $3K |
| 82607 | <1% | 611 | $3K | |
| 83735 | <1% | 1,829 | $2K | |
| 80061 | Lipid panel | <1% | 2,984 | $2K |
| 85610 | <1% | 1,249 | $2K | |
| 81003 | <1% | 1,375 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 721 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,159 | $1K |
| 87077 | <1% | 379 | $1K | |
| A0425 | Ground mileage, per statute mile | <1% | 50 | $1K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 3,219 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 623 | $1K |
| 99335 | <1% | 30 | $1K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 532 | $1K |
| 82728 | <1% | 375 | $1K | |
| 82043 | <1% | 324 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 68 | $984.72 |
| 83540 | <1% | 728 | $966.82 | |
| 98928 | <1% | 100 | $876.47 | |
| 97161 | <1% | 74 | $868.69 | |
| 85027 | <1% | 484 | $824.80 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 26 | $751.32 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 195 | $747.12 |
| 90837 | Psychotherapy session, about an hour | <1% | 173 | $722.69 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 422 | $697.12 |
| 99327 | <1% | 20 | $480.62 | |
| 81001 | <1% | 328 | $410.26 | |
| 83550 | <1% | 283 | $398.42 | |
| 99305 | <1% | 19 | $385.66 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,090 | $380.03 |
| 85652 | <1% | 203 | $288.05 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 31 | $249.41 |
| 82570 | <1% | 64 | $220.48 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 140 | $195.47 |
| 97035 | <1% | 37 | $180.40 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 352 | $180.17 |
| 86140 | <1% | 71 | $165.84 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 524 | $154.51 |
| 83690 | <1% | 160 | $152.09 | |
| 90662 | <1% | 267 | $144.56 | |
| G0008 | Administration of influenza virus vaccine | <1% | 989 | $122.77 |
| 84439 | <1% | 34 | $109.24 | |
| 11055 | <1% | 26 | $100.68 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 26 | $99.05 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 32 | $97.37 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 67 | $94.75 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 29 | $91.06 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 189 | $89.10 |
| 95886 | <1% | 14 | $78.31 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 58 | $78.29 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 17 | $71.71 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 92 | $67.85 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 858 | $58.52 |
| 87205 | <1% | 14 | $50.29 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 85 | $31.70 |
| 99442 | <1% | 27 | $26.60 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 33 | $16.45 |
| 90658 | <1% | 152 | $12.62 | |
| 84484 | <1% | 13 | $8.40 | |
| 0124A | <1% | 14 | $6.94 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 59 | $6.69 |
| 84600 | <1% | 83 | $1.78 | |
| 80076 | <1% | 12 | $1.67 | |
| 90686 | 0% | 169 | $0.00 | |
| 0064A | 0% | 28 | $0.00 | |
| 0001A | 0% | 565 | $0.00 | |
| 0031A | 0% | 42 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 47 | $0.00 |
| 0134A | 0% | 17 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 34 | $0.00 |
| 90480 | 0% | 16 | $0.00 | |
| 0011A | 0% | 123 | $0.00 | |
| 0012A | 0% | 132 | $0.00 | |
| 91300 | 0% | 650 | $0.00 | |
| 81025 | 0% | 13 | $0.00 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 28 | $0.00 |
| 0002A | 0% | 537 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 25 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 32 | $0.00 |
| 0004A | 0% | 48 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 30 | $0.00 |
| 91320 | 0% | 16 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 28 | $0.00 |
| 0071A | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCLARK, RANDALL (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| MRH Corp. | Dover Foxcroft, ME | $3.71M |
| Sebasticook Valley Health | Pittsfield, ME | $3.69M |
| Sebasticook Valley Health | Pittsfield, ME | $2.82M |
| Sebasticook Valley Health | Unity, ME | $1.39M |
| Sebasticook Valley Health | Newport, ME | $1.33M |
| Belle Meade Foundation INC | Richmond, MI | $172K |
| Riverwood Family Medicine PC | Grand Rapids, MI | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.